Treatment for hot flushes and night sweats accepted for regulatory review by EMA
A treatment for moderate to severe vasomotor symptoms (VMS) has been accepted by the European…
September 30, 2022 - 2 minutes
What’s new
Beyond Biotech podcast 16: Adocia, Omnio, Phenomix Sciences, Tridek-One
This week, we have four guests: Olivier Soula, deputy-CEO and director of R&D at Adocia;…
September 30, 2022 - 3 minutes
Kling Biotherapeutics doses first patient in advanced solid tumor trial
Kling Biotherapeutics BV has dosed the first patient with KBA1412 in its phase 1b trial…
September 29, 2022 - 2 minutes
European Science Park Group creates specialized space for innovative industries
ESPG AG – European Science Park Group – is one of the first German real…
September 29, 2022 - 3 minutes
Umeå Biotech Incubator launches international coaching program
The Umeå Biotech Incubator (UBI) in Sweden specializes in developing life science business ideas. Now…
September 29, 2022 - 2 minutes
NeuShen Therapeutics closes $20M pre-A financing
Chinese biotech company NeuShen Therapeutics, Inc. has closed an approximately $20 million series pre-A financing…
September 29, 2022 - 3 minutes
Removing binding sites for an oncogene can slow cancer cell growth, researchers say
Cancer cell growth could be slowed down by removing binding sites for an oncogene, researchers…
September 29, 2022 - 3 minutes
Positive results from study of drug to treat patients with breast cancer published
Results from a phase 1b study of a drug to treat patients with androgen receptor…
September 29, 2022 - 3 minutes
Baseimmune makes future-proof vaccines with AI
Baseimmune is using artificial intelligence (AI) to design vaccines that can protect against future variants…
September 29, 2022 - 6 minutes
Treatment for adults with chronic skin condition approved by FDA
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of…
September 29, 2022 - 4 minutes
Human cells can now help scientists accelerate cure for neurodegenerative diseases
Cell products providing a scalable source of human cells can now help scientists study neurogenerative…
September 29, 2022 - 3 minutes
Positive results from Eisai and Biogen Alzheimer’s trial
Eisai Co., Ltd. and Biogen Inc. have announced positive topline results from Eisai’s large global…
September 29, 2022 - 6 minutes
